Found 68 matching trials
Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma PHASE2 Ovarian clear cell carcinoma (OCCC) is one of the rare subtypes of ovarian ...
Show More Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor PHASE2 The purpose of this research study is to see how useful it is to look at bi...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade PHASE2 This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Show More Location
EuroCityClinic LLC
Learn More & Join Trial
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer. PHASE2 SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Show More Location
Multiple Locations
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma PHASE1 This study will assess the immunomodulatory activity of entinostat in patie...
Show More Location
Indiana University Health Hospital
Learn More & Join Trial
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC PHASE1 The goal of this clinical trial is to evaluate the safety and tolerability ...
Show More Location
Liverpool Cancer Therapy Centre
Learn More & Join Trial
Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer PHASE2 This phase II, open-label, dose-escalation study aims to (1) assess the saf...
Show More Location
Multiple Locations
Learn More & Join Trial
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP PHASE2 This trial is a single-center, prospective, single-arm Phase II clinical st...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial